p53 mutations in tumors derived from irradiated human thyroid epithelial cells

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 425, Issue 2, 1999, Pages 231-238

  Gamble, Simon C ^a   Cook, Myfanwy C ^a   Riches, Andrew C ^b   Herceg, Zdenko ^b   Bryant, Peter E ^b   Arrand, Janet E ^a  

^a BRUNEL UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF ST ANDREWS   (United Kingdom)

Author keywords

Ionizing radiation; p53; Thyroid tumor

Indexed keywords

PROTEIN P53;

ALPHA RADIATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; EPITHELIUM CELL; EXON; GAMMA RADIATION; HUMAN; HUMAN CELL; IONIZING RADIATION; MOUSE; MUTATION; NONHUMAN; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM; THYROID TUMOR;

ALPHA PARTICLES; ANIMALS; CELLS, CULTURED; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; DOSE-RESPONSE RELATIONSHIP, RADIATION; EPITHELIAL CELLS; EXONS; GAMMA RAYS; GENES, P53; HUMANS; LINEAR ENERGY TRANSFER; LUNG; MICE; MICE, NUDE; NEOPLASMS, RADIATION-INDUCED; ORGAN SPECIFICITY; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; THYROID GLAND; THYROID NEOPLASMS;

EID: 0032955285     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0027-5107(99)00045-7     Document Type: Article

References (33)

1. (UNSCEAR) United Nations Scientific Committee on the Effects of Atomic Radiation Report, Suppl. 14 (A/5814), United Nations, New York, 1964.
2. (UNSCEAR) United Nations Scientific Committee on the Effects of Atomic Radiation Sources and Effects of Ionizing Radiation: 1977 report to the General Assembly with annexes, United Nations, New York, 1977, pp. 1-725.
3. D. Williams, A. Pinchera, A. Karaoglou, K.H. Chadwick Thyroid Cancer in Children Living near Chernobyl. Commission of the European Communities. Expert Panel Report on the Consequences of the Chernobyl Accident (EUR 15248 EN), Commission of the European Communities, Luxembourg, 1993.
4. Potter G.D., Lindsay S., Chaikoff I.L. Induction of neoplasms in rat thyroid glands by low doses of radioiodine. Arch. Pathol. 69:1960;257-269.
5. A.J. Levine, The p53 tumor suppressor gene and product, in: Cancer Surveys Vol. 12, Tumor suppressor genes, the cell cycle and cancer Imperial cancer research fund, 1992, pp. 59-70.
6. Baker S.J., Preisinger A.C., Jessup J.M., Paraskeva C., Markovitz S., Willson J.K.V., Hamilton S., Vogelstein B. p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis. Cancer Res. 50:1990;7717-7722.
7. Nigro J.M., Baker S.J., Preisinger A.C., Jessup J.M., Hostetter R., Cleary K., Bigner S.H., Davidson N., Baylin S., Devilee P., Collins F.S., Weston A., Modali R., Harris C.C., Vogelstein B. Mutations in the p53 gene occur in diverse human tumour types. Nature. 342:1989;705-708.
8. Miller C.W., Simon K., Aslo A., Kok K., Buys C.H.C.M., Terada M., Koeffler H.P. p53 mutations in human lung tumours. Cancer Res. 52:1992;1695-1698.
9. Lu X., Lane D.P. Differential induction of transcriptionally active p53 following UV or ionizing radiation: defects in chromosome instability syndromes. Cell. 75:1993;765-778.
10. Balcer-Kubiczec E.K., Yin J., Lin K., Harrison G.H., Abraham J.M., Meltzer S.J. p53 mutational status and survival of human breast cancer MCF-7 cell variants after exposure to X-rays or fission neutrons. Radiat. Res. 142:1995;256-262.
11. Kastan M.B., Onyekwere O., Sidransky D., Vogelstein B., Craig R.W. Participation of p53 protein in the cellular response to DNA damage. Cancer Res. 51:1991;6304-6311.
12. Murakami Y., Hayashi K., Hirohashi S., Takao S. Aberations of the tumour suppressor p53 and retinoblastoma genes in human hepatocellular carcinomas. Cancer Res. 51:1991;5520-5525.
13. Bögler O., Huang H.J.S., Cavanee W.K. Loss of wild-type p53 bestows a growth advantage on primary cortical astrocytes and facilitates their in vitro transformation. Cancer Res. 55:1995;2746-2751.
14. Van Meir E.G., Kikuchi T., Tada M., Li H., Diserens A.C., Wojcik B.E., Huang H.J.S., Freidmann T., de Tribolet N., Cavanee W.K. Analysis of the p53 gene and its expression in human glioblastoma cells. Cancer Res. 54:1994;649-652.
15. Vähäkanagas K.H., Samet J.M., Metcalf R.A., Welsh J.A., Bennett W.P., Lane D.P., Harris C.C. Mutation of p53 and ras genes in radon associated lung cancer from uranium miners. Lancet. 339:1992;576-580.
16. Taylor J.A., Watson M.A., Devereux T.R., Michels R.Y., Saccomanno G., Anderson M. p53 mutation hotspot in radon-associated lung cancer. Lancet. 343:1994;86-87.
17. Hillbrebrandt S., Streffer C., Reiners C.H.R., Demidchik E. Mutations in the p53 tumour suppressor gene in thyroid tumours of children from areas contaminated by the Chernobyl accident. Int. J. Radiat. Biol. 69:1996;39-45.
18. Lemoine N.S., Mayall E.S., Jones T., Sheer D., McDermid S., Kendall-Taylor P., Wynford-Thomas D. Characterisation of human thyroid epithelial cells immortalised in vitro by simian virus 40 DNA transfection. Br. J. Cancer. 60:1989;897-903.
19. Riches A.C., Herceg Z., Bryant P.E., Wynford-Thomas D. Radiation-induced transformation of SV40-immortalized human thyroid epithelial cells by single and fractionated exposure to gamma-irradiation in vitro. Int. J. Radiat. Biol. 66:1994;757-765.
20. Riches A.C., Herceg Z., Bryant P.E., Stevens D.L., Goodhead D.T. Radiation induced transformation of SV40-immortalised human thyroid epithelial cells by single exposure to plutonium alpha particles in vitro. Int. J. Radiat. Biol. 72:1997;515-521.
21. Lehman T.A., Modali R., Boukamp P., Stanek J., Bennet W.P., Welsh J.A., Metcalf R.A., Stampfer M.R., Fusenig N., Rogan E.M., Harris C.C. p53 mutations in human immortalized epithelial cell lines. Carcinogenesis. 14:1993;833-839.
22. Chomczynski P. A reagent for the single step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples. Biotechniques. 15:1993;532-537.
23. Weinberg R. Oncogenes, antioncogenes and the molecular bases of multistep carcinogenesis. Cancer Res. 49:1989;3713-3721.
24. Klein G. The approaching era of the tumour suppressor genes. Science. 238:1987;1539-1545.
25. Bishop J.M. The molecular genetics of cancer. Science. 235:1987;305-311.
26. Mothersill C., Harney J., Seymour C.B. Induction of stable p53 oncoprotein and of c-myc over-expression in cultured normal human urothelium by radiation and N-nitrosodiethanolamine. Radiation Res. 142:1995;181-187.
27. Hollstein M., Sidransky D., Vogelstien B., Harris C.C. p53 mutations in human cancers. Science. 253:1991;49-53.
28. Toguchida J., Yamaguchi T., Ritchie B., Beauchamp R.L., Dayton S.H., Herrera G.E., Yamamuro T., Kotuora Y., Sasaki M.S., Little J.B., Weischelbaum R.J., Ishizaki K., Yandell D.W. Mutation spectrum of the p53 gene in bone and soft tissue sarcomas. Cancer Res. 52:1992;6194-6199.
29. Slichenmeter W.J., Nelson W.G., Slebos R.J., Kastan M.B. Loss of a p53 associated G1 checkpoint does not decrease cell survival following DNA damage. Cancer Res. 53:1993;4164-4168.
30. Wright P.A., Lemoine N.R., Goretzki P.E., Wyllie F.S., Bond J., Hughes C. Mutation of the p53 gene in a differentiated human thyroid carcinoma. Oncogene. 6:1991;1693-1697.
31. Zou M., Shi Y., Farad N.R. p53 mutations in all stages of thyroid carcinogenesis. J. Clin. Endocrinol. Metab. 77:1993;1054-1058.
32. Donghi R., Longoni A., Pilotti S., Michieli P., Porta G.D. Gene p53 mutations are restricted to poorly differentiated and undifferentiated carcinomas of the thyroid gland. J. Clin. Invest. 91:1993;1753-1760.
33. Ito T., Seyama T., Mizuno T.et al. Unique association of p53 mutations with undifferentiated but not with differentiated carcinomas of the thyroid gland. Cancer Res. 52:1992;1369-1371.